Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2).
| Autor: | Stechschulte LA, Ge C, Hinds TD Jr, Sanchez ER, Franceschi RT, Lecka-Czernik B |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of biological chemistry [J Biol Chem] 2018 May 25; Vol. 293 (21), pp. 8314. |
| DOI: | 10.1074/jbc.W118.003815 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|